Viscoelastic solution for injection into the joint space OST ^® Plus is a medical device indicated for the treatment of pain and limited joint mobility caused by, among others, injuries and degenerative diseases. The OST ^® Plus 40 mg/2 ml pre-filled syringe contains 2 ml of 2% hyaluronic acid solution obtained by biofermentation, without animal proteins. The structure of hyaluronic acid mimics the one present in the human body. The hyaluronic acid contained in the solution is stabilized with mannitol 0.5%. Mannitol is a natural antioxidant and has strong anti-radical properties. Protects hyaluronic acid from degradation.

Intra-articular injection - benefits

Synovial fluid has lubricating and shock-absorbing properties and is also responsible for nourishing the articular cartilage. It is found in all synovial joints, especially those exposed to heavy loads. Hyaluronic acid is responsible for its viscoelastic properties. In degenerative joint diseases, such as osteoarthritis, the viscoelastic properties of the fluid are significantly affected. This causes a deterioration of the lubrication and shock-absorbing properties and leads to an increase in the mechanical load on the joints and the destruction of the articular cartilage. The result is pain and limited joint mobility.

The injection increases the concentration of hyaluronic acid in the joint. Supplementing the synovial fluid with intra-articular injections of highly purified hyaluronic acid improves its viscoelastic properties. This, in turn, improves its lubrication and shock-absorbing properties and reduces the mechanical overload of the joint.

The OST ^® Plus package contains 1 pre-filled syringe of 40 mg/2.0 ml in a sterile package.